215 related articles for article (PubMed ID: 30571405)
1. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
[TBL] [Abstract][Full Text] [Related]
2. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
[TBL] [Abstract][Full Text] [Related]
5. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging drug treatment strategies for peripheral arterial disease.
Essa H; Torella F; Lip GYH
Expert Opin Pharmacother; 2020 Sep; 21(13):1603-1616. PubMed ID: 32558590
[TBL] [Abstract][Full Text] [Related]
7. Statins and peripheral arterial disease.
Markel A
Int Angiol; 2015 Oct; 34(5):416-27. PubMed ID: 25410295
[TBL] [Abstract][Full Text] [Related]
8. Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.
Arya S; Khakharia A; Binney ZO; DeMartino RR; Brewster LP; Goodney PP; Wilson PWF
Circulation; 2018 Apr; 137(14):1435-1446. PubMed ID: 29330214
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral arterial disease: Treatment].
Desormais I; Aboyans V; Pesteil F; Lacroix P
Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
[TBL] [Abstract][Full Text] [Related]
10. Underuse of Cardiovascular Medications in Individuals With Known Lower Extremity Peripheral Artery Disease: HCHS/SOL.
Hua S; Isasi CR; Kizer JR; Matsushita K; Allison MA; Tarraf W; Qi Q; Ponce SG; Daviglus M; Kaplan RC
J Am Heart Assoc; 2020 Aug; 9(16):e015451. PubMed ID: 32752978
[TBL] [Abstract][Full Text] [Related]
11. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.
Polonsky TS; McDermott MM
JAMA; 2021 Jun; 325(21):2188-2198. PubMed ID: 34061140
[TBL] [Abstract][Full Text] [Related]
12. The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention.
Hart O; Xue N; Khashram M
ANZ J Surg; 2023 Oct; 93(10):2376-2381. PubMed ID: 37370242
[TBL] [Abstract][Full Text] [Related]
13. Limited Adherence to Peripheral Arterial Disease Guidelines and Suboptimal Ankle Brachial Index Reliability in Dutch Primary Care.
Hageman D; Pesser N; Gommans LNM; Willigendael EM; van Sambeek MRHM; Huijbers E; Snoeijen A; Scheltinga MRM; Teijink JAW
Eur J Vasc Endovasc Surg; 2018 Jun; 55(6):867-873. PubMed ID: 29576335
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of peripheral arterial disease.
Hankey GJ; Norman PE; Eikelboom JW
JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
[TBL] [Abstract][Full Text] [Related]
16. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
[TBL] [Abstract][Full Text] [Related]
17. Medical and lifestyle management of peripheral arterial disease.
Parvar SL; Fitridge R; Dawson J; Nicholls SJ
J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
[TBL] [Abstract][Full Text] [Related]
19. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
Poredos P; Jezovnik MK
Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based analysis of peripheral arterial disease screening based on the WHO criteria.
Shah S; Antoniou GA; Torella F
Int Angiol; 2017 Aug; 36(4):299-305. PubMed ID: 26344513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
